Share
Journal Information
Most cited
52
COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICUMaría Laura Vega, Roberto Dongilli, Gustavo Olaizola, Nicolás Colaianni, Mauro Castro Sayat, Lara Pisani, Micaela Romagnoli, Greta Spoladore, ... Stefano Nava
Pulmonol. 2022;28:13-7
52
Open access
34
Feasibility of tele-rehabilitation in survivors of COVID-19 pneumoniaM. Paneroni, M. Vitacca, P. Bernocchi, L. Bertacchini, S. Scalvini
Pulmonol. 2022;28:152-4
34
Open access
33
Virtual reality for COPD rehabilitation: a technological perspectiveV. Colombo, A. Aliverti, M. Sacco
Pulmonol. 2022;28:119-33
33
Open access
32
Bronchoscopic sampling techniques in the era of technological bronchoscopyM. Mondoni, R.F. Rinaldo, P. Carlucci, S. Terraneo, L. Saderi, S. Centanni, G. Sotgiu
Pulmonol. 2022;28:461-71
32
Open access
29
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort studyRoberto Tonelli, Lara Pisani, Luca Tabbì, Vittoria Comellini, Irene Prediletto, Riccardo Fantini, Alessandro Marchioni, Dario Andrisani, ... Enrico Clini
Pulmonol. 2022;28:181-92
29
Open access
Open Article
28
Connective tissue disease-associated interstitial lung diseaseR.P. Oliveira, R. Ribeiro, L. Melo, B. Grima, S. Oliveira, J.D. Alves
Pulmonol. 2022;28:113-8
28
Open access
27
Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressureN. De Vita, L. Scotti, G. Cammarota, F. Racca, C. Pissaia, C. Maestrone, D. Colombo, C. Olivieri, ... for COVID-19 Eastern Piedmont Network
Pulmonol. 2022;28:173-80
27
Open access
Open Article
22
Impact of the COVID-19 pandemic on tuberculosis servicesI. Rodrigues, A. Aguiar, G.B. Migliori, R. Duarte
Pulmonol. 2022;28:210-9
22
Open access
Open Article
22
Issue 1 - “Update on adverse respiratory effects of outdoor air pollution”. Part 1): Outdoor air pollution and respiratory diseases: A general update and an Italian perspectiveS. De Matteis, F. Forastiere, S. Baldacci, S. Maio, S. Tagliaferro, S. Fasola, G. Cilluffo, S. La Grutta, G. Viegi
Pulmonol. 2022;28:284-96
22
Open access
21
First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary diseaseK. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae
Pulmonol. 2022;28:6-12
21
Open access
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
